News Search Results

Displaying Results 876-900 of 1917 "COVID-19"

Sep 03, 2025, 11:17 ET Los Angeles Parents Reach Historic Settlement with L.A. Unified School District in Education Equity Lawsuit

California's largest school district and the second largest school district in the country, adopted and implemented distance learning policies during COVID-19 school closures that violated students' constitutional and statutory rights. They asserted claims for adopting distance learning policies that both

More news about: Kirkland & Ellis LLP


Sep 03, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against iRobot Corporation and Certain Officers - IRBT

was the first commercially successful RVC, iRobot's business has steadily declined over the past decade, apart from a brief sales bump during the COVID-19 pandemic. Competitors from China undercut the luxury-priced Roomba, while other consumer electronics firms like Samsung

More news about: Pomerantz LLP


Sep 03, 2025, 08:53 ET 16 Years of Data: Clean Restrooms Drive Loyalty, Repeat Visits, and Revenue

experienceThese preferences represent a permanent shift in public expectations. Over the past ten years, and especially in the wake of COVID-19, their importance has surged with the most dramatic gains between 2020 and 2022. Today, cleanability, hygiene, and convenience are no longer extras;

More news about: Bradley Company


Sep 03, 2025, 08:46 ET Leonardo DiCaprio Pens Foreword to Data at the Edge, a Five-Book Series on Finding Trusted GIS Data

Holm Nicolas Holm is a GIS & AI innovator and educator. He mapped Tibet for the Dalai Lama and built an early COVID-19 warning system. His tools have helped prevent U.S. veteran suicides, guided Ukrainians to safety, and helped halt oil drilling in the Amazon. Featured

More news about: Nicolas Holm


Sep 03, 2025, 08:41 ET Hyro Launches Proactive Px™ with AI Agent to Help Healthcare Organizations Handle Coverage Disruption Caused by OBBBA

to ensure that the solution remains sustainable and available to as many health systems and patients as possible. "When the world faced the COVID-19 pandemic in 2020, we created AI chat and voice agents to alleviate stress on health systems and their staff," said Israel

More news about: Hyro


Sep 03, 2025, 08:34 ET Newsmax Television Anchor and Columnist Tom Basile Joins Catholic Speakers Organization

politics and policy. During his two-decades-plus career he's been in the middle of some of the most pressing stories, covering presidential campaigns, COVID-19, three presidential inaugurations, and other major breaking news events. In 2025, he provided hours of daily coverage of the Papal Conclave that elected

More news about: Catholic Speakers Organization


Sep 03, 2025, 08:34 ET Coya Therapeutics to Participate at Upcoming September Investor Conferences

and unknown risks, uncertainties, assumptions and other factors including, but not limited to, those related to risks associated with the impact of COVID-19; the success, cost and timing of our product candidate development activities and ongoing and planned clinical trials; our plans to develop and commercialize

More news about: Coya Therapeutics, Inc.


Sep 03, 2025, 08:30 ET Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®

are offering the 3-in-1 combo test, which allows patients to be tested for Influenza A, Influenza B and COVID-19 with one swab. In states that allow pharmacists to both test for and treat COVID-19 and flu, patients can be tested and assessed by a CVS pharmacist for antiviral treatment in one appointment.

More news about: CVS/pharmacy


Sep 03, 2025, 08:30 ET AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

cells, and decreased platelets. In follicular lymphoma the most common side effects of EPKINLY include injection site reactions, CRS, COVID-19, tiredness, upper respiratory tract infections, muscle and bone pain, rash, diarrhea, fever, cough, and headache. The most common severe abnormal

More news about: AbbVie


Sep 03, 2025, 08:01 ET Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Long COVID symptoms by the removal of circulating COVID-19 spike protein. The 453 Patent is intended to protect the use of the Hemopurifier® for the treatment of patients that lack circulating COVID-19 viral particles but exhibit COVID-19-associated CAC. The 260 Patent was granted

More news about: Aethlon Medical, Inc.


Sep 02, 2025, 19:55 ET LINE STOCK NEWS: Lineage, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action

customer demand, as additional cold-storage supply had come on line, Lineage's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and Lineage's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends;

More news about: Robbins LLP


Sep 02, 2025, 10:45 ET Vaccines Market worth $63.66 billion in 2030 with 4.8% CAGR | MarketsandMarkets™

vaccines, HPV, meningococcal disease, herpes zoster, rotavirus, MMR, varicella, hepatitis, DTP, polio, RSV, and other disease indications (cancer, COVID-19, dengue, tuberculosis, typhoid, Japanese encephalitis, rabies, yellow fever, and allergies). In 2024, pneumococcal disease held the largest share of

More news about: MarketsandMarkets


Sep 02, 2025, 09:00 ET Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

more than 20 years of expertise in research and development, manufacturing, and commercialization of syndromic real-time PCR technologies. During the COVID-19 pandemic, Seegene supplied more than 340 million tests to over 100 countries, underscoring its global impact. Seegene's proprietary syndromic

More news about: Seegene Inc.


Sep 02, 2025, 09:00 ET Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

more than 20 years of expertise in research and development, manufacturing, and commercialization of syndromic real-time PCR technologies. During the COVID-19 pandemic, Seegene supplied more than 340 million tests to over 100 countries, underscoring its global impact. Seegene's proprietary syndromic

More news about: Seegene Inc.


Sep 02, 2025, 09:00 ET Ohio Connections Academy Begins 2025-2026 School Year Serving Students Statewide

Connections Academy this year. A competitive and accomplished barrel racer, Kaila and her twin sister first enrolled in the online school during the COVID-19 pandemic before briefly going back to their local brick-and-mortar school. "They returned to their local school, but we observed that they

More news about: Connections Academy


Sep 02, 2025, 08:45 ET Shareholders that lost money on Lineage, Inc.(LINE) should contact Levi & Korsinsky about pending Class Action - LINE

customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer

More news about: Levi & Korsinsky, LLP


Sep 02, 2025, 08:44 ET Credibly Launches Second Annual Small Business Awards to Empower Entrepreneurs With $60,000 in Award Money

alternative lender's portfolio ($250 million). Credibly has achieved steady growth, operated continuously throughout the COVID-19 pandemic, and has consistently recorded exceptional origination numbers. Media Contact Jenny BeresPink

More news about: Credibly


Sep 02, 2025, 07:30 ET Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known

More news about: SOLIGENIX, INC.


Sep 01, 2025, 10:01 ET Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™.

providers and patients. Moreover, Abbott's proactive response during global health emergencies, such as its rapid deployment of immunoassay-based COVID-19 tests, has reinforced its reputation as a trusted diagnostic partner. These efforts collectively strengthen Abbott's position as a leading innovator

More news about: MarketsandMarkets


Aug 29, 2025, 12:00 ET Lineage, Inc. (LINE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Aug 29, 2025, 10:00 ET Thomas Rabe carries on the legacy of the 'Good Man of Nanjing'

provided our family and the exchange center," Thomas Rabe said. He recalled that during the most challenging period of the Covid-19 pandemic he wrote to the then-ambassador Wu seeking help. Shortly thereafter, batches of medicine, protective suits, masks and disinfectant from

More news about: China.org.cn


Aug 29, 2025, 07:00 ET Lanvin Group Reports H1 2025 Revenue of €133 Million Operational Discipline and Early Recovery Momentum Set Foundation for Growth in H2

growth rate, profitability and market opportunity may not be an indication of its actual results or future results; management of growth; the impact of COVID-19 or similar public health crises on Lanvin Group's business; Lanvin Group's ability to safeguard the value, recognition and reputation of its brands

More news about: LANVIN GROUP


Aug 29, 2025, 06:20 ET Vaccine Refrigerators Market Size to Reach US$ 2.50 Billion by 2033 with 7.6% CAGR, Report by DataM Intelligence

reliable cold storage has become the backbone of successful immunization programs worldwide. Most vaccines, including those for measles, polio, HPV, and COVID-19 boosters, require storage at 2°C to 8°C, making standard medical-grade refrigerators indispensable across hospitals, pharmacies, and community health

More news about: DataM Intelligence 4 Market Research LLP


Aug 29, 2025, 01:23 ET UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

forward-looking statements contained in this press release. Important factors that could result in such differences include: the global spread and impact of COVID-19, changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable

More news about: UCB


Aug 29, 2025, 01:15 ET UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

forward-looking statements contained in this press release. Important factors that could result in such differences include: the global spread and impact of COVID-19, changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable

More news about: UCB


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.